Evaluation of Antibody Response After Vaccination with Inactivated SARS-CoV-2 Vaccine in Health Workers

Basit Öğe Kaydı
dc.authorwosidGürcan, Şaban/D-2754-2017
dc.contributor.authorDavarci, Ismail
dc.contributor.authorEryildiz, Canan
dc.contributor.authorGurcan, Saban
dc.date.accessioned2024-06-12T10:51:55Z
dc.date.available2024-06-12T10:51:55Z
dc.date.issued2021
dc.departmentTrakya Üniversitesien_US
dc.description.abstractCOVID-19, which emerged in Wuhan in December 2019 and spread all over the world, is an infectious disease. Vaccine studies have been started rapidly by many centers. One of them is the inactive CoronaVac vaccine of Sinovac Company. Turkey has given approval for the emergency use of CoronaVac. In this study, it was aimed to investigate the antibody responses to the vaccine in health workers who work in high-risk departments for COVID-19 in our university and are vaccinated with CoronaVac. Health workers participating in the study were divided into the vaccine group and control group. Forty-one people from the vaccine group and 12 people from the control group volunteered to our study. The vaccine and control group samples taken 14 days after the first dose of vaccine were studied with anti SARS-CoV-2 IgG (Euroimmun, Germany). The antibody levels of four people in the vaccine group could not be examined after the second dose of vaccine due to reasons such as resignation and annual permit. Antibody levels were not measured in the control group after the second dose of vaccine. The antibody level after the first dose was found to be 9.8% and 0% in the vaccine group and control group, respectively. After the second dose of the vaccine, this rate was found to be 94.6% in the vaccine group. Based on the current findings, it is thought that a single dose of the vaccine cannot produce an antibody response at the desired rate in the study group, and it is essential to comply with personal protection rules until social immunity reaches the desired levels.en_US
dc.identifier.doi10.5578/flora.20219813
dc.identifier.endpage343en_US
dc.identifier.issn1300-932X
dc.identifier.issue2en_US
dc.identifier.startpage338en_US
dc.identifier.trdizinid521073en_US
dc.identifier.urihttps://doi.org/10.5578/flora.20219813
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/521073
dc.identifier.urihttps://hdl.handle.net/20.500.14551/18533
dc.identifier.volume26en_US
dc.identifier.wosWOS:000715129900015en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isotren_US
dc.publisherBilimsel Tip Yayinevien_US
dc.relation.ispartofFlora Infeksiyon Hastaliklari Ve Klinik Mikrobiyoloji Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAntibodyen_US
dc.subjectVaccineen_US
dc.subjectCOVID-19en_US
dc.subjectSinovacen_US
dc.titleEvaluation of Antibody Response After Vaccination with Inactivated SARS-CoV-2 Vaccine in Health Workersen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu